Pfizer pic

Pfizer to buy Allergan in $160 billion deal to create world’s biggest drugmaker

Pfizer, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan in a transaction valued at about $160 billion. 

The complex deal, the biggest ever in the healthcare sector, will allow Pfizer to shift its legal base to Ireland. Pfizer’s chief executive Ian Read will be CEO of the combined company, while Allergan CEO Brent Saunders will be chief operating Officer, the companies said today. 

New York-based Pfizer and Allergan – headquartered in Ireland – said Allergan shareholders will receive 11.3 shares in the combined company for each share held. The deal values Allergan’s shares at $363.63 each, compared with the stock’s close of $312.46 on Friday. Pfizer stockholders will have the option of receiving one share of the combined company for each of their Pfizer shares or receive cash, provided the aggregate amount of cash to be paid is not less than $6 billion or more than $12 billion. 

The tax aspect of the deal has been seen as critical. The US corporate tax rate of 35% is among the world’s highest, and compares with Ireland’s rate of 12.5%. Upon the closing of the transaction in the second half of 2016, the companies said the combined company was expected to maintain Allergan’s Irish legal domicile. 

For More please click: 


We use cookies to give you the best online experience. By agreeing you consent the use of cookies in accordance with our Privacy Statement and cookie settings in your Privacy Settings below.

Privacy Settings saved!
Privacy Settings

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie

Decline all Services
Accept all Services